meloxicam orion 15 mg tabletti
orion corporation - meloxicam - tabletti - 15 mg - meloksikaami
ketesse 25 mg rakeet oraaliliuosta varten
menarini international operations luxembourg s.a. - dexketoprofenum trometamolum - rakeet oraaliliuosta varten - 25 mg - deksketoprofeeni
ibuprofen accord 400 mg tabletti, kalvopäällysteinen
accord healthcare b.v. - ibuprofen - tabletti, kalvopäällysteinen - 400 mg - ibuprofeeni
ibuprofen accord 600 mg tabletti, kalvopäällysteinen
accord healthcare b.v. - ibuprofen - tabletti, kalvopäällysteinen - 600 mg - ibuprofeeni
skudexa 75 mg / 25 mg tabletti, kalvopäällysteinen
menarini international operations luxembourg s.a. - tramadol hydrochloride, dexketoprofen trometamol - tabletti, kalvopäällysteinen - 75 mg / 25 mg - tramadoli ja deksketoprofeeni
okitask 25 mg rakeet
dompe farmaceutici s.p.a - ketoprofen lysinate - rakeet - 25 mg - ketoprofeeni
okitask 25 mg tabletti, kalvopäällysteinen
dompe farmaceutici s.p.a - ketoprofen lysinate - tabletti, kalvopäällysteinen - 25 mg - ketoprofeeni
ketesse 25 mg oraaliliuos, annospussi
menarini international operations luxembourg s.a. - dexketoprofen trometamol - oraaliliuos, annospussi - 25 mg - deksketoprofeeni
imfinzi
astrazeneca ab - durvalumab - karsinooma, ei-pienisoluinen keuhko - antineoplastiset aineet - non-small cell lung cancer (nsclc)imfinzi as monotherapy is indicated for the treatment of locally advanced, unresectable non small cell lung cancer (nsclc) in adults whose tumours express pd-l1 on ≥ 1% of tumour cells and whose disease has not progressed following platinum based chemoradiation therapy (see section 5. imfinzi in combination with tremelimumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic nsclc with no sensitising egfr mutations or alk positive mutations. small cell lung cancer (sclc)imfinzi in combination with etoposide and either carboplatin or cisplatin is indicated for the first-line treatment of adults with extensive-stage small cell lung cancer (es-sclc). biliary tract cancer (btc)imfinzi in combination with gemcitabine and cisplatin is indicated for the first line treatment of adults with unresectable or metastatic biliary tract cancer (btc). hepatocellular carcinoma (hcc)imfinzi in combination with tremelimumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc).
skudexa 75 mg / 25 mg rakeet oraaliliuosta varten, annospussi
menarini international operations luxembourg s.a. - tramadol hydrochloride, dexketoprofen trometamol - rakeet oraaliliuosta varten, annospussi - 75 mg / 25 mg - tramadoli ja deksketoprofeeni